Research progress of sulforaphane in treatment of Helicobacter pylori
infection

doi:10.3760/cma.j.issn.1007-1245.2022.07.033

Abstract

Abstract:

The problem of Helicobacter pylori (Hp) infection is still serious in China, and there are still some deficiencies in the current treatment plan based on antibiotics. Studies have found that sulforaphane (SFN), a natural plant active substance, can improve the eradication rate and reduce adverse reactions by enhancing the body's antioxidant ability, inhibiting the growth and colonization of Hp and directly killing Hp infection. This paper reviews the research progress of SFN in the treatment of Hp infection, hoping to provide new ideas for the treatment of Hp infection.

Key words: Sulforaphane, Helicobacter pylori, Treatment

摘要： 我国幽门螺杆菌（Helicobacter pylori，Hp）感染问题仍较严重，目前以抗生素为主的治疗方案仍存在部分不足。研究发现，萝卜硫素（sulforaphane，SFN）这一天然植物活性物质，通过增强机体抗氧化性，抑制Hp生长定植以及对Hp的直接杀伤作用治疗Hp感染，可以提高根除率，减轻不良反应。本文综述了SFN治疗Hp的研究进展，希望为Hp的治疗提供新思路。

关键词: 萝卜硫素, 幽门螺杆菌, 治疗

Wang Hao, Xie Qingzhi. Research progress of sulforaphane in treatment of Helicobacter pylori infection[J]. International Medicine and Health Guidance News, 2022, 28(7): 1021-1024.

王浩, 谢庆芝. 萝卜硫素治疗幽门螺杆菌感染的研究进展[J]. 国际医药卫生导报, 2022, 28(7): 1021-1024.

References

[1] Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report[J]. Gut, 2017,66(1):6-30. DOI: 10.1136/gutjnl-2016-312288.

[2] 刘文忠."第五次全国幽门螺杆菌感染处理共识报告"解读[J].胃肠病学,2017,22(6):321-324.DOI:10.3969/j.issn.1008-7125.2017.06.001.

[3] 薛宇,朱艳丽,张晨晨,等. 药物治疗幽门螺旋杆菌及其多药耐药性的研究现状及发展趋势[J]. 广东化工,2021,48(7):77-78. DOI:10.3969/j.issn.1007-1865.2021.07.031.

[4] Antonopoulos DA, Huse SM, Morrison HG, et al. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation[J]. Infect Immun, 2009,77(6):2367-2375. DOI: 10.1128/IAI.01520-08.

[5] Wang Y, Wu H, Dong N, et al. Sulforaphane induces S-phase arrest and apoptosis via p53-dependent manner in gastric cancer cells[J]. Sci Rep, 2021,11(1):2504. DOI: 10.1038/s41598-021-81815-2.

[6] Zheng Z, Lin K, Hu Y, et al. Sulforaphane metabolites inhibit migration and invasion via microtubule-mediated Claudins dysfunction or inhibition of autolysosome formation in human non-small cell lung cancer cells[J]. Cell Death Dis, 2019,10(4):259. DOI: 10.1038/s41419-019-1489-1.

[7] Liu P, Atkinson SJ, Akbareian SE, et al. Sulforaphane exerts anti-angiogenesis effects against hepatocellular carcinoma through inhibition of STAT3/HIF-1α/VEGF signalling[J]. Sci Rep, 2017,7(1):12651. DOI: 10.1038/s41598-017-12855-w.

[8] Yoo IH, Kim MJ, Kim J, et al. The anti-inflammatory effect of sulforaphane in mice with experimental autoimmune encephalomyelitis[J]. J Korean Med Sci, 2019,34(28):e197. DOI: 10.3346/jkms.2019.34.e197.

[9] Fahey JW, Haristoy X, Dolan PM, et al. Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors[J]. Proc Natl Acad Sci U S A, 2002,99(11):7610-7615. DOI: 10.1073/pnas.112203099.

[10] Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer[J]. N Engl J Med, 2001,345(11):784-789. DOI: 10.1056/NEJMoa001999.

[11] Bhattacharyya A, Chattopadhyay R, Mitra S, et al. Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases[J]. Physiol Rev, 2014,94(2):329-354. DOI: 10.1152/physrev.00040.2012.

[12] Sivapalan T, Melchini A, Saha S, et al. Bioavailability of glucoraphanin and sulforaphane from high-glucoraphanin broccoli[J]. Mol Nutr Food Res, 2018,62(18):e1700911. DOI: 10.1002/mnfr.201700911.

[13] Pall ML, Levine S. Nrf2, a master regulator of detoxification and also antioxidant, anti-inflammatory and other cytoprotective mechanisms, is raised by health promoting factors[J]. Sheng Li Xue Bao, 2015,67(1):1-18.

[14] Houghton CA, Fassett RG, Coombes JS. Sulforaphane and other nutrigenomic Nrf2 activators: can the clinician's expectation be matched by the reality?[J]. Oxid Med Cell Longev, 2016,2016:7857186. DOI: 10.1155/2016/7857186.

[15] Su X, Jiang X, Meng L, et al. Anticancer activity of sulforaphane: the epigenetic mechanisms and the Nrf2 signaling pathway[J]. Oxid Med Cell Longev, 2018,2018:5438179. DOI: 10.1155/2018/5438179.

[16] Yanaka A, Fahey JW, Fukumoto A, et al. Dietary sulforaphane-rich broccoli sprouts reduce colonization and attenuate gastritis in Helicobacter pylori-infected mice and humans[J]. Cancer Prev Res (Phila), 2009,2(4):353-360. DOI: 10.1158/1940-6207.CAPR-08-0192.

[17] Yanaka A, Sato J, Ohmori S. Sulforaphane protects small intestinal mucosa from aspirin/NSAID-induced injury by enhancing host defense systems against oxidative stress and by inhibiting mucosal invasion of anaerobic enterobacteria[J]. Curr Pharm Des, 2013,19(1):157-162. DOI: 10.2174/13816128130120.

[18] Galan MV, Kishan AA, Silverman AL. Oral broccoli sprouts for the treatment of Helicobacter pylori infection: a preliminary report[J]. Dig Dis Sci, 2004,49(7-8):1088-1090. DOI: 10.1023/b:ddas.0000037792.04787.8a.

[19] Sato K, Kawakami N, Ohtsu T, et al. Broccoli consumption and chronic atrophic gastritis among Japanese males: an epidemiological investigation[J]. Acta Med Okayama, 2004,58(3):127-133. DOI: 10.18926/AMO/32109.

[20] Marcus EA, Moshfegh AP, Sachs G, et al. The periplasmic alpha-carbonic anhydrase activity of Helicobacter pylori is essential for acid acclimation[J]. J Bacteriol, 2005,187(2):729-738. DOI: 10.1128/JB.187.2.729-738.2005.

[21] Weeks DL, Eskandari S, Scott DR, et al. A H+-gated urea channel: the link between Helicobacter pylori urease and gastric colonization[J]. Science, 2000,287(5452):482-485. DOI: 10.1126/science.287.5452.482.

[22] Debowski AW, Walton SM, Chua EG, et al. Helicobacter pylori gene silencing in vivo demonstrates urease is essential for chronic infection[J]. PLoS Pathog, 2017,13(6):e1006464. DOI: 10.1371/journal.ppat.1006464.

[23] Wroblewski LE, Shen L, Ogden S, et al. Helicobacter pylori dysregulation of gastric epithelial tight junctions by urease-mediated myosin II activation[J]. Gastroenterology, 2009,136(1):236-246. DOI: 10.1053/j.gastro.2008.10.011.

[24] Valenzuela-Valderrama M, Cerda-Opazo P, Backert S, et al. The Helicobacter pylori urease virulence factor is required for the induction of hypoxia-induced factor-1α in gastric cells[J]. Cancers (Basel), 2019,11(6):799. DOI: 10.3390/cancers11060799.

[25] de Jesus Souza M, de Moraes JA, Da Silva VN, et al. Helicobacter pylori urease induces pro-inflammatory effects and differentiation of human endothelial cells: Cellular and molecular mechanism[J]. Helicobacter, 2019,24(3):e12573. DOI: 10.1111/hel.12573.

[26] Fahey JW, Stephenson KK, Wade KL, et al. Urease from Helicobacter pylori is inactivated by sulforaphane and other isothiocyanates[J]. Biochem Biophys Res Commun, 2013,435(1):1-7. DOI: 10.1016/j.bbrc.2013.03.126.

[27] Haristoy X, Fahey JW, Scholtus I, et al. Evaluation of the antimicrobial effects of several isothiocyanates on Helicobacter pylori[J]. Planta Med, 2005,71(4):326-330. DOI: 10.1055/s-2005-864098.

[28] Haristoy X, Angioi-Duprez K, Duprez A, et al. Efficacy of sulforaphane in eradicating Helicobacter pylori in human gastric xenografts implanted in nude mice[J]. Antimicrob Agents Chemother, 2003,47(12):3982-3284. DOI: 10.1128/AAC.47.12.3982-3984.2003.

[29] Mirmiran P, Bahadoran Z, Golzarand M, et al. A comparative study of broccoli sprouts powder and standard triple therapy on cardiovascular risk factors following H.pylori eradication: a randomized clinical trial in patients with type 2 diabetes[J]. J Diabetes Metab Disord, 2014,13:64. DOI: 10.1186/2251-6581-13-64.

[30] Lewinska A, Adamczyk-Grochala J, Deregowska A, et al. Sulforaphane-induced cell cycle arrest and senescence are accompanied by DNA hypomethylation and changes in microRNA profile in breast cancer cells[J]. Theranostics, 2017,7(14):3461-3477. DOI: 10.7150/thno.20657.

[31] Naumann P, Liermann J, Fortunato F, et al. Sulforaphane enhances irradiation effects in terms of perturbed cell cycle progression and increased DNA damage in pancreatic cancer cells[J]. PLoS One, 2017,12(7):e0180940. DOI: 10.1371/journal.pone.0180940.

[32] Choi YH. ROS-mediated activation of AMPK plays a critical role in sulforaphane-induced apoptosis and mitotic arrest in AGS human gastric cancer cells[J]. Gen Physiol Biophys, 2018,37(2):129-140. DOI: 10.4149/gpb_2017026.

[33] Park SY, Kim GY, Bae SJ, Yoo YH, Choi YH. Induction of apoptosis by isothiocyanate sulforaphane in human cervical carcinoma HeLa and hepatocarcinoma HepG2 cells through activation of caspase-3[J]. Oncol Rep, 2007 ,18(1):181-187.

[34] Lan H, Yuan H, Lin C. Sulforaphane induces p53deficient SW480 cell apoptosis via the ROSMAPK signaling pathway[J]. Mol Med Rep, 2017,16(5):7796-7804. DOI: 10.3892/mmr.2017.7558.

[35] Sestili P, Paolillo M, Lenzi M, et al. Sulforaphane induces DNA single strand breaks in cultured human cells[J]. Mutat Res, 2010,689(1-2):65-73. DOI: 10.1016/j.mrfmmm.2010.05.003.

[36] Santos PW, Machado ART, De Grandis R, et al. Effects of sulforaphane on the oxidative response, apoptosis, and the transcriptional profile of human stomach mucosa cells in vitro[J]. Mutat Res Genet Toxicol Environ Mutagen, 2020,854-855:503201. DOI: 10.1016/j.mrgentox.2020.503201.

[37] Chang YW, Park YM, Oh CH, et al. Effects of probiotics or broccoli supplementation on Helicobacter pylori eradication with standard clarithromycin-based triple therapy[J]. Korean J Intern Med, 2020,35(3):574-581. DOI: 10.3904/kjim.2019.139.

Research progress of sulforaphane in treatment of Helicobacter pylori infection

萝卜硫素治疗幽门螺杆菌感染的研究进展

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 13

Recommended Articles

Metrics

[1]	Wei Jianwen, Yin Wenjun, Chen Zekai, Ling Muan, Chen Jie, Pan Bin. Observation of clinical efficacy of early electrophysiological technology intervention in restoring urine control function after laparoscopic radical resection of prostate cancer [J]. International Medicine and Health Guidance News, 2022, 28(8): 1038-1041.
[2]	Qin Shuipen. Current situation and research progress of clinical treatment of diabetic retinopathy [J]. International Medicine and Health Guidance News, 2022, 28(8): 1180-1184.
[3]	Liu Zhilong, He Jing, Li Chongyu. Clinical experience of treating fever [J]. International Medicine and Health Guidance News, 2022, 28(7): 916-919.
[4]	Zhao Jing, Zheng Aiping. Ultrasound in diagnosis and treatment of tendon diseases of lower extremities [J]. International Medicine and Health Guidance News, 2022, 28(7): 953-956.
[5]	Liu jing, Gai Xinxin, Liang Sen, Wei Xuegong. Research progress in etiology, diagnosis, and treatment of placenta previa [J]. International Medicine and Health Guidance News, 2022, 28(7): 1029-1033.
[6]	Tian Jie, Jin Yu, Liu Suqin. Research progress of plastic bronchitis in children [J]. International Medicine and Health Guidance News, 2022, 28(6): 805-808.
[7]	Tang Ming, Huang Wei. Idiopathic portal hypertension with gastrointestinal bleeding as first manifestation: a case report [J]. International Medicine and Health Guidance News, 2022, 28(6): 870-872.
[8]	Wang Wen, Cui Xiujuan, Tian Xiangyu. Diagnosis and treatment of endometriosis complicated with adenomyosis [J]. International Medicine and Health Guidance News, 2022, 28(5): 687-691.
[9]	Wu Xueting, Chen Xiaoyi, Wu Yiwen, Cai Yongna, Xiao Mingyue, Chen Fengjuan, Han Qianglin, Qiu Shaodong, Zhu Zhiming, Chen Fei. Advances in the application of ultrasound radiomics in breast cancer [J]. International Medicine and Health Guidance News, 2022, 28(4): 484-487.
[10]	Weng Yijie, Li Liangsheng, Zhong Xiangxin, Deng Feifu, Wang Yichang, Wei Jinsong. Diagnosis and treatment of osteoporosis and current status of treatment with mesenchymal stem cells [J]. International Medicine and Health Guidance News, 2022, 28(3): 315-320.
[11]	Yu Wenlong, Yin Xiaowei, Yang Yuzhu, Xu Yanmei. One case of giant breast adenosquamous carcinoma and literature review [J]. International Medicine and Health Guidance News, 2022, 28(3): 419-421.
[12]	Guan Ruoping, Dai Guokui, Jiang Guli, Li Yue, Xu Yan. Analysis of Helicobacter pylori infection and related factors among public officials in Guangzhou [J]. International Medicine and Health Guidance News, 2022, 28(2): 284-287.
[13]	Jiang Xin, Gao Xuefeng, She Qiang, Ding Yanbing. Individualized precise eradication of Helicobacter pylori [J]. International Medicine and Health Guidance News, 2022, 28(1): 32-37.